Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
11030657 | Atherosclerosis | 2018 | 6 Pages |
Abstract
These results imply that only a small proportion of FH patients achieved the recommended LDL-Ch treatment targets, mostly due to the use of low statin dose and infrequent implementation of high-intensity statin treatment, which altogether could not prevent the increase in residual cardiovascular risk.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Katarina LaliÄ, NataÅ¡a RajkoviÄ, Ljiljana PopoviÄ, Sandra Singh LukaÄ, Ljubica StoÅ¡iÄ, Iva RasuliÄ, NebojÅ¡a M. LaliÄ,